Dashboard
Manage Tickers

COEPCoeptis Therapeutics Holdin...

Nasdaq coeptispharma.com


$ 0.19 $ -0.01 (-2.89 %)    

Friday, 13-Sep-2024 10:24:13 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 474.86 $ 2.12 (0.45 %)
DIA $ 414.87 $ 2.97 (0.72 %)
SPY $ 561.82 $ 2.92 (0.52 %)
TLT $ 100.40 $ 0.27 (0.27 %)
GLD $ 238.66 $ 2.35 (0.99 %)
$ 0.1882
-- x --
-- x --
-- - --
$ 0.17 - $ 1.38
40,133
na
7.48M
$ 0.32
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-16-2024 06-30-2024 10-Q
2 05-10-2024 03-31-2024 10-Q
3 03-25-2024 12-31-2023 10-K
4 11-09-2023 09-30-2023 10-Q
5 08-11-2023 06-30-2023 10-Q
6 05-15-2023 03-31-2023 10-Q
7 03-29-2023 12-31-2022 10-K
8 11-18-2022 09-30-2022 10-Q
9 08-09-2022 06-30-2022 10-Q
10 05-10-2022 03-31-2022 10-Q
11 04-08-2022 12-31-2021 10-K
12 11-16-2021 09-30-2021 10-Q
13 09-14-2021 06-30-2021 10-Q
14 07-30-2021 03-31-2021 10-Q
15 03-31-2021 12-31-2020 10-K
16 12-10-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

coeptis-therapeutics-ceo-updates-shareholders-on-recent-milestones-including-phase-1-trial-completion-strategic-partnerships-and-capital-raises-with-plans-for-continued-growth-in-cell-therapy-platforms-and-nasdaq-listing-appeal
Coeptis Therapeutics CEO Updates Sharehold...
09/05/2024 12:19:41

Dear Coeptis Therapeutics

why-digital-turbine-shares-are-trading-higher-by-over-20-here-are-20-stocks-moving-premarket
Why Digital Turbine Shares Are Trading Hig...
08/08/2024 10:02:17

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
05/22/2024 12:06:41

coeptis-therapeutics-to-present-universal-allogeneic-snap-car-nk-cell-therapy-at-isct-2024-from-may-28-to-june-1
Coeptis Therapeutics To Present Universal ...
05/08/2024 12:56:40

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
04/04/2024 20:31:22

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
03/26/2024 21:32:33

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
03/14/2024 21:33:37

coeptis-therapeutics-adds-autoimmune-indications-to-exclusive-license-agreement-with-university-of-pittsburgh-for-snap-car-t-and-snap-car-nk
Coeptis Therapeutics Adds Autoimmune Indic...
02/26/2024 14:02:34

Exclusive rights to universal CAR technology platform designed to target multiple antigens simultaneously, recently expanded to...

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
02/12/2024 21:30:59

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
02/08/2024 21:31:10

coeptis-therapeutics-plans-to-pursue-dvx201-its-proprietary-allogeneic-stem-cell-expansion-and-directed-differentiation-platform-of-unmodified-natural-killer-cell-therapy-as-an-antiviral-treatment-addressing-various-respiratory-viral-infections
Coeptis Therapeutics Plans To Pursue DVX20...
02/07/2024 12:40:46

collective-audience-and-3-other-stocks-under-1-insiders-are-buying
Collective Audience And 3 Other Stocks Und...
01/18/2024 13:54:58

The Dow Jones index closed lower by around 100 points on Wednesday. When insiders purchase or sell shares, it indicates their c...

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
01/17/2024 21:31:08

coeptis-therapeutics-sets-sights-on-expanding-cancer-and-autoimmune-treatments-in-2024
Coeptis Therapeutics Sets Sights on Expand...
01/04/2024 12:38:02

Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) (the "Company" or "Coeptis"), a biopharmaceutical company dev...

coeptis-therapeutics-announces-research-demonstrating-the-potential-of-snap-car-t-cells-to-reduce-tumor-burden-and-growth-in-her2-and-cd20-expressing-cancers-will-be-presented-at-sitc-2023
Coeptis Therapeutics Announces Research De...
10/31/2023 13:05:34

 Poster presentation describes the development of SNAP CAR platform technology as a "universal" CAR therapy with the po...

coeptis-therapeutics-has-expanded-its-exclusive-license-agreement-with-the-university-of-pittsburgh-to-include-the-snap-car-technology-platform-in-natural-killer-cells
Coeptis Therapeutics Has Expanded Its Excl...
10/11/2023 11:37:24

This amended agreement builds upon the original exclusive license agreement with the University of Pittsburgh for SNAP-CAR T-Ce...

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
09/28/2023 21:31:12

benzingas-top-ratings-upgrades-downgrades-for-september-22-2023
Benzinga's Top Ratings Upgrades, Downgrade...
09/22/2023 15:00:39

ladenburg-thalmann-initiates-coverage-on-coeptis-therapeutics-with-buy-rating-announces-price-target-of-3
Ladenburg Thalmann Initiates Coverage On C...
09/22/2023 11:49:19

Ladenburg Thalmann analyst Aydin Huseynov initiates coverage on Coeptis Therapeutics (NASDAQ:COEP) with a Buy rating and ann...

coeptis-therapeutics-phase-1-trials-of-dvx201-for-relapsedrefractory-acute-myeloid-leukemia-or-high-risk-myelodysplastic-syndrome-and-hospitalized-covid-19-patients-showed-no-dose-limiting-toxicities-cytokine-release-syndrome-or-infusion-toxicities
Coeptis Therapeutics' Phase 1 Trials Of DV...
09/14/2023 11:35:35

Coeptis Expects To Report Topline Safety And Efficacy Data From The Full Patient Population In Q1 Of 2024

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION